Cargando…

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.

Human papillomavirus (HPV) is the main risk factor for invasive cervical cancer. High risk ratios are found in cross-sectional data on HPV prevalence. The question raised is whether this present evidence is sufficient for making firm recommendations on HPV screening. A validated cervical cancer scre...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Ballegooijen, M., van den Akker-van Marle, M. E., Warmerdam, P. G., Meijer, C. J., Walboomers, J. M., Habbema, J. D.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228006/ https://www.ncbi.nlm.nih.gov/pubmed/9303366

Ejemplares similares

Extended duration of the detectable stage by adding HPV test in cervical cancer screening
por: van den Akker-van Marie, M E, et al.
Publicado: (2003)

Low risk of cervical cancer during a long period after negative screening in the Netherlands
por: van den Akker-van Marle, M E, et al.
Publicado: (2003)

A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusions
por: Cuzick, J, et al.
Publicado: (2000)

Non-progression of cervical intraepithelial neoplasia estimated from population-screening data.
por: Bos, A. B., et al.
Publicado: (1997)

Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
por: Naber, Steffie K., et al.
Publicado: (2016)

Cost‐effectiveness of HPV‐based cervical screening based on first year results in the Netherlands: a modelling study
por: Jansen, EEL, et al.
Publicado: (2020)

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.
por: Cromme, F. V., et al.
Publicado: (1993)

Preventive Pap-smears: balancing costs, risks and benefits.
por: van Ballegooijen, M., et al.
Publicado: (1992)

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing
por: van Rosmalen, J, et al.
Publicado: (2012)

HPV types and cofactors causing cervical cancer in Peru
por: Santos, C, et al.
Publicado: (2001)

Cost reduction in screening for retinopathy of prematurity in the Netherlands by comparing different screening strategies
por: Trzcionkowska, Kasia, et al.
Publicado: (2022)

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening
por: de Kok, I M C M, et al.
Publicado: (2009)

Cervical cancer screening.
por: van Oortmarrsen, G. J., et al.
Publicado: (1990)

Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
por: Rebolj, Matejka, et al.
Publicado: (2012)

Population Screening for Colorectal Cancer: Faeces, Endoscopes or X-Rays?
por: Ramsoekh, D., et al.
Publicado: (2007)

Relational coordination in value-based health care
por: van Staalduinen, Dorine J., et al.
Publicado: (2023)

The implementation of value-based healthcare: a scoping review
por: van Staalduinen, Dorine J., et al.
Publicado: (2022)

Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge
por: Narayen, Ilona C., et al.
Publicado: (2018)

Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: The FIT@Home study
por: Kraal, Jos J, et al.
Publicado: (2013)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

The Role of Acquired Immunity in the Spread of Human Papillomavirus (HPV): Explorations with a Microsimulation Model
por: Matthijsse, Suzette M., et al.
Publicado: (2015)

A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears
por: Jacobs, M V, et al.
Publicado: (2000)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction.
por: de Roda Husman, A. M., et al.
Publicado: (1995)

Clinical value and cost analysis of the sFlt-1/PlGF ratio in addition to the spot urine protein/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study
por: Wind, M., et al.
Publicado: (2022)

Implementation of a shared care guideline on the lumbosacral radicular syndrome: effects on unnecessary referrals, waiting time and costs
por: Fleuren, M.A.H., et al.
Publicado: (2009)

Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands
por: Brouwers, Rutger W. M., et al.
Publicado: (2021)

Incidence of cervical cancer after several negative smear results by age 50: prospective observational study
por: Rebolj, Matejka, et al.
Publicado: (2009)

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
por: Rijkaart, D C, et al.
Publicado: (2012)

Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study
por: Kraal, Jos J, et al.
Publicado: (2017)

(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient’s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)
por: Kruiswijk, Anouk A, et al.
Publicado: (2023)

Cost‐effectiveness of three internet‐based interventions for eating disorders: A randomized controlled trial
por: Rohrbach, Pieter J., et al.
Publicado: (2022)

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
por: Petry, K-U, et al.
Publicado: (2003)

HPV infection in women with and without cervical cancer in Conakry, Guinea
por: Keita, N, et al.
Publicado: (2009)

Human papillomavirus and invasive cervical cancer in Brazil.
por: Eluf-Neto, J., et al.
Publicado: (1994)

Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer.
por: van Oortmarssen, G. J., et al.
Publicado: (1991)

Correction: Preventive child health care at elementary school age: The costs of routine assessments with a triage approach
por: Bezem, Janine, et al.
Publicado: (2017)

Assessment of cytotoxic T-lymphocyte phenotype using the specific markers granzyme B and TIA-1 in cervical neoplastic lesions.
por: Bontkes, H. J., et al.
Publicado: (1997)

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
por: de Kok, Inge M C M, et al.
Publicado: (2012)

Costs and effects of conventional vision screening and photoscreening in the Dutch preventive child health care system
por: Van der Ploeg, Catharina P B, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sahcsokrbqjd4hvn83hoku534f